GlassScriptPhysician profile
Anurag Singh
NPI 1871673319
$12,503.94
in general payments reported to CMS, 2019-2025
22 companies · $3,192 in 2025
The $3,192 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,438 · 2020: $2,233 · 2021: $941 · 2022: $1,819 · 2023: $742 · 2024: $1,138 · 2025: $3,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,198 · Consulting Fee: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,197.93 |
| Consulting Fee | $1,875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $5,173.42 | 2019-2025 | Carto 3, Smartablatetm System Rf Generator |
| Medtronic Vascular, INC. | $2,086.49 | 2019-2020 | |
| Altathera Pharmaceuticals LLC | $2,080.97 | 2025 | Sotalol Hydrochloride |
| Medtronic, INC. | $1,036.29 | 2021-2025 | Micra, Arctic Front Advance, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $922.87 | 2019-2025 | General - Therapies, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $135.55 | 2024-2025 | Igt Devices Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Atricure, INC. | $134.33 | 2019-2021 | |
| Amgen INC. | $125.01 | 2025 | Repatha |
| Volta Medical INC | $112.08 | 2024 | Vx1 |
| Impulse Dynamics (USA) INC. | $104.55 | 2022-2023 | Optimizer |
| Abbott Laboratories | $99.06 | 2024 | Gallant, Ensite |
| E.R. Squibb & Sons, L.L.C. | $90.81 | 2024-2025 | Eliquis, Camzyos |
| Pfizer INC. | $89.37 | 2024-2025 | |
| Cardiofocus, INC. | $70.14 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.19 | 2024-2025 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $44.29 | 2024 | Xarelto |
| Abiomed | $31.23 | 2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $31.06 | 2024 | Brilinta, Lokelma |
| Cook Medical LLC | $21.51 | 2023 | Zilver Ptx |
| Cardiva Medical, INC. | $20.47 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.01 | 2025 | Jardiance |
| Irhythm Technologies, INC. | $16.24 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anurag Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.